Development of phosphocellulose paper-based screening of inhibitors of lipid kinases: case study with PI3Kβ

Mahesh Yanamandra1, Labanyamoy Kole2, Archana Giri3

  • 1Biology Division, GVK Biosciences Pvt. Ltd., Hyderabad 500076, Andhra Pradesh, India; Centre for Biotechnology, Institute of Science and Technology, Jawaharlal Nehru Technological University Hyderabad, 500085 Hyderabad, Andhra Pradesh, India.

Analytical Biochemistry
|January 2, 2014
PubMed

Insights

Researchers developed a novel radioactive assay for screening phosphatidylinositol 3-kinases (PI3K) inhibitors. This phosphocellulose plate assay enables efficient identification of new drug candidates for cancer and metabolic disorders.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Drug Discovery

Background:

  • Phosphatidylinositol 3-kinases (PI3Ks) are crucial lipid kinases regulating vital cellular processes.
  • Dysregulation of PI3K pathways is implicated in oncogenesis and metabolic disorders.
  • Developing effective PI3K inhibitors is challenging due to difficulties in lipid kinase screening.

Purpose of the Study:

  • To establish a novel radioactive screening platform for lipid kinases.
  • To validate the platform's utility for identifying PI3K inhibitors.

Main Methods:

  • Development of a phosphocellulose plate-based assay using radiolabeled [γ-(32)P]ATP.
  • Quantification of phosphatidylinositol 3,4,5-phosphate formation.
  • Enzyme kinetics and inhibitor profiling using known PI3K inhibitors (LY294002, TGX-221, wortmannin).

Main Results:

  • The assay successfully measures PI3K activity and inhibitor potency.
  • Kinetic parameters (Km) and IC50 values were accurately determined.
  • The platform demonstrated reliability by matching historical data for standard inhibitors.

Conclusions:

  • A novel, efficient radioactive phosphocellulose plate assay for PI3K was developed.
  • This platform is suitable for identifying novel chemical entities for PI3K-targeted drug discovery.
  • The assay provides a valuable tool for advancing PI3K inhibitor development.

Related Concept Videos

Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
7.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
12.1K